These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9410698)

  • 1. [Oncogenes, differentiation markers and morphological criteria as prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M; Junker K
    Dtsch Med Wochenschr; 1997 Oct; 122(43):1327-31. PubMed ID: 9410698
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological perspectives].
    Pujol JL; Demoly P; Quantin X; Simony J; Parrat E; Lehmann M; Daurès JP; Jolimoy G; Grenier J; Pau B; Godard P
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):428-40. PubMed ID: 9690313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M
    Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchial cancer. Mechanisms of bronchial oncogenesis].
    Krespine C
    Soins; 1994 Dec-1995 Jan; (591-592):3-4, 6. PubMed ID: 7652603
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lung tumors. Pathologic-anatomic diagnosis].
    Müller KM; Theile A
    Internist (Berl); 1994 Aug; 35(8):710-23. PubMed ID: 7960551
    [No Abstract]   [Full Text] [Related]  

  • 6. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Should the extended evaluation of bronchial adenocarcinoma be different from that of non-small cell lung carcinoma?].
    Milleron B; Guigay J; Rugeri L; Rosencher L; Terrioux P; Beerblock K; Akoun G
    Rev Pneumol Clin; 1992; 48(4):159-62. PubMed ID: 1338351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic strategy and treatment planning in bronchial cancer].
    Drings P
    Radiologe; 1990 Apr; 30(4):149-54. PubMed ID: 2160669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New prognostic factors in bronchogenic cancer].
    Navío Martín P; Pérez Rodríguez E; Sueiro Bendito A
    Rev Clin Esp; 1998 Sep; 198(9):604-9. PubMed ID: 9803782
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in non-small cell lung carcinoma.
    Koutsami MK; Gorgoulis VG; Kastrinakis NG; Asimacopoulos PJ; Kittas C
    Anticancer Res; 2002; 22(1A):347-74. PubMed ID: 12017316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tumors of the lung. Pathology and molecular biology.
    Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
    Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
    Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoscopic and invasive approach].
    Ninane V; Bosschaerts T
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):351-62. PubMed ID: 9690305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New cell biology research on the development of bronchial cancer].
    Lorenz J
    Internist (Berl); 1994 Aug; 35(8):692-9. PubMed ID: 7960549
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
    von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
    Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
    Gazdar AF; Mulshine JL; Kramer BS
    Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.